Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial

NCT04234360 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04234360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04234360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Lead sponsor
University Hospital, Montpellier
Phase
Phase 3
Overall status
Terminated
Start date
October 12, 2021
Completion date
January 30, 2025
Enrollment
182 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation